Early planning & development

  • Parexel Biotech – a patient-centric approach is in our DNA4:24

    Parexel Biotech – a patient-centric approach is in our DNA

    Hear firsthand from Monica about her personal journey as a clinical trial participant to understand the value of easing patient burden

    Watch Video
  • Contact Us with your Biotech needs!

    Email Us
  • Parexel Biotech Brochure

    Parexel Biotech Brochure

    Read More
  • Parexel Biotech – designed with biotech’s unique way of working in mind2:55

    Parexel Biotech – designed with biotech’s unique way of working in mind

    James Anthony, SVP, Global Head Biotech and Graciela Rácaro, SVP, Global Head, Biotech Operations, both from Parexel, discuss how Parexel Biotech has been built to meet customer and patient needs

    Watch Video
  • The hidden value of early patient centricity: practical solutions for early phase trials

    The hidden value of early patient centricity: practical solutions for early phase trials

    Learn about five economical and efficient ways to make early phase trials both patient-centric and more effective.

    Read More
  • Plan & engage early to manage the risks of risk management

    Plan & engage early to manage the risks of risk management

    Read More
  • Early Phase Clinical Unit Tour - Berlin

    Early Phase Clinical Unit Tour - Berlin

    Learn More
  • Early Phase Clinical Unit Tour - Los Angeles

    Early Phase Clinical Unit Tour - Los Angeles

    Learn More
  • Navigating the Increasing Complexity of Drug Biomarker Co-Development

    Navigating the Increasing Complexity of Drug Biomarker Co-Development

    Learn about five steps that will help companies better manage the complexity and risk of working with targeted medicines.

    Read More
  • Early Phase Clinical Unit Tour - Baltimore

    Early Phase Clinical Unit Tour - Baltimore

    Take a tour

    Learn More
  • How Protocol Optimization Improves Clinical Trial Outcomes

    How Protocol Optimization Improves Clinical Trial Outcomes

    Improve clinical trial outcomes and prevent costly delays.

    Read More
  • Opportunities for biotechs in precision medicine: bringing important new therapies to patients and value to the company

    Opportunities for biotechs in precision medicine: bringing important new therapies to patients and value to the company

    For biotech companies, precision medicine holds tremendous promise for innovation – for newly designed drugs, new technologies for drug delivery, and engineered cell or gene therapies.

    Read More
  • Drug development innovations that work: Precision medicine

    Drug development innovations that work: Precision medicine

    Learn more about new regulatory frameworks for precision medicine and how best to demonstrate results for regulatory bodies.

    Learn More
  • Patient registries: Defining the patient2:15

    Patient registries: Defining the patient

    Parexel’s Leanne Larson, Corporate VP and WW Head, Real-world Evidence speaks with Deborah Collyar, cancer survivor and President of Advocates in Research about the importance of Real-world Evidence (

    Watch Video
  • Genomics & biomarkers: Answers in the blood2:53

    Genomics & biomarkers: Answers in the blood

    Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi

    Watch Video
  • Cell and gene therapies: for biotechs, collaboration is key to successful innovation

    Cell and gene therapies: for biotechs, collaboration is key to successful innovation

    Learn more about what to look for in the right CRO partner to overcome logistical and operational challenges in cell and gene therapy product development.

    Read More
  • Commercial and regulatory strategy considerations for biotech

    Commercial and regulatory strategy considerations for biotech

    In this blog, Parexel regulatory and strategy experts tackle the question of how we can ensure that worthy innovations in the biotech pipeline make it to patients sooner.

    Learn More
  • RWE in an evolving regulatory landscape: Using real-world evidence to support novel product development pathways

    RWE in an evolving regulatory landscape: Using real-world evidence to support novel product development pathways

    In this on-demand webinar, Parexel experts discuss the growing interest in RWE from both regulators and payors and the advantages of using real-world data (RWD) to streamline the research process.

    Learn More
  • Using real-world evidence to help your product succeed

    Using real-world evidence to help your product succeed

    Let us show you how our experience of leveraging real-world data (RWD) and real-world evidence (RWE) can help your product launch succeed.

    Read More
  • loading
    Loading More...